EMEA-001757-PIP02-15-M01

Key facts

Active substance
Copanlisib
Therapeutic area
Oncology
Decision number
P/0133/2020
PIP number
EMEA-001757-PIP02-15-M01
Pharmaceutical form(s)
Powder for solution for injection
Condition(s) / indication(s)
Treatment of all conditions included in the category of malignant neoplasms (except haematopoietic and lymphoid tissue neoplasms)
Route(s) of administration
Intravenous use
Contact for public enquiries
Bayer AG
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating